Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...
Smarter design through targeted delivery and human-relevant testing can save the industry from costly safety failures.
Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing ...
What happens when seeking emotional fix becomes an industry? This investigation shows how therapy culture—replacing social reform, political action, and community care—has encouraged emotional ...
Melanoma is a type of skin cancer that begins in melanocytes, the pigment-producing cells of the skin. It is considered the most serious form of skin cancer. Your diagnosis of Stage 2 Melanoma means ...
Here’s what experts are learning about this chaotic period leading up to menopause—including what causes its symptoms, when it really begins, and how to treat it.
The efficacy of systemic therapy varies among patients with rare skin cancers, but patients with cutaneous adnexal carcinoma have poor outcomes regardless of the therapy they receive, according to ...
For dermatology, this may be less about replacing minoxidil and more about reframing its role within a broader toolkit.
Women using menopausal hormone therapy have up to a 30% lower risk of developing esophageal and gastric cancers, with the ...
Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients ...
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...